FDA approves first-of-its-kind nasal spray for severe depression
This treatment is delivered through a nasal spray and relies not on ketamine, but one of its two primary components called esketamine. The end result, Spravato has since been approved in …
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
21 hours ago · A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & …
FDA allows standalone use of nasal spray antidepressant Spravato ...
3 days ago · The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for …
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
2 days ago · Spravato nasal spray is administered by the patient under the supervision of a health care provider in a health care setting. Spravato targets the neurotransmitter glutamate; …
FDA Approves Nasal Spray for Depression - Newsweek
2 days ago · This new treatment could help bring relief for millions of Americans struggling with depression. What To Know. The nasal spray Spravato, which is made from the drug …
SPRAVATO® (esketamine): A Prescription Nasal Spray
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, reduces depression symptoms when two or more oral antidepressants haven't worked. …
FDA approves new nasal spray medication for treatment-resistant ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried...
Spravato Nasal Spray: Uses, Dosage, Side Effects - Drugs.com
Aug 23, 2023 · Spravato (esketamine) nasal spray is used for treatment-resistant depression and major depressive disorder (MDD) with acute suicidal ideation or behavior. Includes Spravato …
Esketamine for Treatment-Resistant Depression - Johns Hopkins Medicine
But it wasn’t until recently that esketamine, a more potent version of ketamine, earned FDA approval specifically for use as a nasal spray for those with treatment-resistant depression. …
Nose spray to treat depression? FDA approves first-of-its-kind
Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen ...